Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.54 |
| ▸ | TSHR | P16473 | 7/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.44 |
| ▸ | TP53 | P04637 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.43 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.43 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | USP2 | O75604 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29396329 | 0.83 | ALDH1A1 (0.59) | ALDH1A1TSHRTDP1L3MBTL1CYP3A4 | |
| SCHEMBL8036928 | 0.83 | ALDH1A1 (0.59) | ALDH1A1TSHRTDP1L3MBTL1CYP3A4 | |
| SCHEMBL9935576 | 0.83 | ALDH1A1 (0.59) | ALDH1A1TSHRTDP1MAPK1LMNA | |
| SCHEMBL226501 | 0.79 | ALDH1A1 (0.86) | ALDH1A1TSHRTDP1L3MBTL1CYP3A4 | |
| SCHEMBL186286 | 0.79 | TSHR (0.86) | ALDH1A1TSHRTDP1L3MBTL1CYP3A4 | |
| Phthalic Acid SCHEMBL27873885 | 0.79 | ALDH1A1 (0.86) | ALDH1A1TSHRTDP1L3MBTL1CYP3A4 | |
| Phthalic Acid SCHEMBL29007201 | 0.79 | ALDH1A1 (0.86) | ALDH1A1TSHRTDP1L3MBTL1CYP3A4 | |
| SCHEMBL29601593 | 0.79 | ALDH1A1 (0.86) | ALDH1A1TSHRTDP1L3MBTL1CYP3A4 | |
| Phthalic Acid SCHEMBL19667985 | 0.79 | ALDH1A1 (0.86) | ALDH1A1TSHRTDP1L3MBTL1CYP3A4 | |
| Phthalic Acid SCHEMBL29285130 | 0.79 | ALDH1A1 (0.86) | ALDH1A1TSHRTDP1L3MBTL1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107207456-B | Latent acids and their use | 巴斯夫欧洲公司 | 2021-05-04 | — | — | CN | disclosed |
| EP-3253735-B1 | LATENT ACIDS AND THEIR USE | BASF SE (DE) | 2021-03-31 | — | — | EP | disclosed |
| US-10133175-B2 | Photosensitive resin composition, cured product and method for producing same, method for producing resin pattern, cured film, liquid crystal display device, organic el display device, infrared cut filter, and solid-state imaging device | FUJIFILM CORPORATION (JP) | 2018-11-20 | — | — | US | disclosed |
| US-9994538-B2 | Latent acids and their use | BASF SE (DE) | 2018-06-12 | — | — | US | disclosed |
| US-9964848-B2 | Positive photosensitive resin composition and cured film forming method using the same | FUJIFILM CORPORATION (JP) | 2018-05-08 | — | — | US | disclosed |
| US-20180009775-A1 | LATENT ACIDS AND THEIR USE | BASF SE (DE) | 2018-01-11 | — | — | US | disclosed |
| EP-2420890-B1 | Positive photosensitive resin composition, method for forming cured film and liquid crystal display device | FUJIFILM CORP (JP) | 2017-03-01 | — | — | EP | disclosed |
| EP-2613198-B1 | PHOTOSENSITIVE RESIN COMPOSITION, OXIME SULFONATE COMPOUND, METHOD FOR FORMING CURED FILM, CURED FILM, ORGANIC EL DISPLAY DEVICE, AND LIQUID CRYSTAL DISPLAY DEVICE | FUJIFILM CORP (JP) | 2016-12-28 | — | — | EP | disclosed |
| US-20160320529-A1 | PHOTOSENSITIVE RESIN COMPOSITION, CURED PRODUCT AND METHOD FOR PRODUCING SAME, METHOD FOR PRODUCING RESIN PATTERN, CURED FILM, LIQUID CRYSTAL DISPLAY DEVICE, ORGANIC EL DISPLAY DEVICE, INFRARED CUT FILTER, AND SOLID-STATE IMAGING DEVICE | FUJIFILM CORPORATION (JP) | 2016-11-03 | — | — | US | disclosed |
| WO-2016124493-A1 | LATENT ACIDS AND THEIR USE | BASF SE (DE) | 2016-08-11 | — | — | WO | disclosed |
| EP-2420890-A1 | Positive photosensitive resin composition, method for forming cured film, cured film, organic el display device and liquid crystal display device | Fujifilm Corporation (JP) | 2012-02-22 | — | — | EP | disclosed |
| US-20110229661-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND CURED FILM FORMING METHOD USING THE SAME | C/O FUJIFILM CORPORATION (JP) | 2011-09-22 | — | — | US | disclosed |
| US-20110177302-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND METHOD OF FORMING CURED FILM FROM THE SAME | FUJIFILM CORPORATION (JP) | 2011-07-21 | — | — | US | disclosed |
| EP-2261737-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND METHOD OF FORMING CURED FILM FROM THE SAME | FUJIFILM Corporation (JP) | 2010-12-15 | — | — | EP | disclosed |
| US-20100173246-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND METHOD FOR FORMING CURED FILM USING THE SAME | FUJIFILM CORPORATION (JP) | 2010-07-08 | — | — | US | disclosed |
| EP-2196852-A1 | POSITIVE-TYPE PHOTOSENSITIVE RESIN COMPOSITION, AND METHOD FOR FORMATION OF CURED FILM USING THE SAME | Fujifilm Corporation (JP) | 2010-06-16 | — | — | EP | disclosed |
| US-20100119973-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND CURED FILM FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2010-05-13 | — | — | US | disclosed |
| EP-2154571-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND METHOD OF FORMING CURED FILM THEREFROM | Fujifilm Corporation (JP) | 2010-02-17 | — | — | EP | disclosed |
| EP-2130095-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND CURED FILM FORMING METHOD USING THE SAME | Fujifilm Corporation (JP) | 2009-12-09 | — | — | EP | disclosed |
| WO-2008123563-A1 | POSITIVE PHOTOSENSITIVE RESIN COMPOSITION AND CURED FILM FORMING METHOD USING THE SAME | FUJIFILM CORPORATION (JP) | 2008-10-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180009775-A1 | LATENT ACIDS AND THEIR USE | LTA, C1S, C9 | ALDH1A1 217/4885TSHR 3529/4885TDP1 3849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.